Autoantibody Systems in Rheumatoid Arthritis: Specificity, Sensitivity and Diagnostic Value

Overview

Journal Arthritis Res

Specialty Rheumatology

Date 2002 Mar 7

PMID 11879544

Citations 106

Authors

Martinus A M van Boekel

Erik R Vossenaar

Frank H J van den Hoogen

Walther J van Venrooij

Affiliations

Soon will be listed here.

Abstract

The diagnosis of rheumatoid arthritis (RA) is primarily based on clinical symptoms, so it is often difficult to diagnose RA in very early stages of the disease. A disease-specific autoantibody that could be used as a serological marker would therefore be very useful. Most autoimmune diseases are characterized by a polyclonal B-cell response targeting multiple autoantigens. These immune responses are often not specific for a single disease. In this review, the most important autoantibody/autoantigen systems associated with RA are described and their utility as a diagnostic and prognostic tool, including their specificity, sensitivity and practical application, is discussed. We conclude that, at present, the antibody response directed to citrullinated antigens has the most valuable diagnostic and prognostic potential for RA.

Citing Articles

What Could Lead to the Production of Anti-Rheumatoid Antibodies in Patients with Brucellosis Spondylodiscitis: Possible Causes.

Khaidarova Y, Kurmanova G, Nurgaliyeva G, Omarova M Med J Islam Repub Iran. 2024; 38:89.

PMID: 39678769 PMC: 11644106. DOI: 10.47176/mjiri.38.89.

Crossing epigenetic frontiers: the intersection of novel histone modifications and diseases.

Yao W, Hu X, Wang X Signal Transduct Target Ther. 2024; 9(1):232.

PMID: 39278916 PMC: 11403012. DOI: 10.1038/s41392-024-01918-w.

Increased gene expression of CCR6 and RORγt in peripheral blood cells of rheumatoid arthritis patients and their correlation with anti-cyclic citrullinated peptide and disease activity.

Roghani S, Lotfi R, Soroush M, Khorasanizadeh A, Feizollahi P, Assar S Immun Inflamm Dis. 2023; 11(12):e1112.

PMID: 38156398 PMC: 10698821. DOI: 10.1002/iid3.1112.

The role of glycolytic metabolic pathways in cardiovascular disease and potential therapeutic approaches.

Chen S, Zou Y, Song C, Cao K, Cai K, Wu Y Basic Res Cardiol. 2023; 118(1):48.

PMID: 37938421 PMC: 10632287. DOI: 10.1007/s00395-023-01018-w.

Geraniol Suppresses Oxidative Stress, Inflammation, and Interstitial Collagenase to Protect against Inflammatory Arthritis.

Malik M, Tahir M, Alsahli T, Tusher M, Alzarea S, Alsuwayt B ACS Omega. 2023; 8(40):37128-37139.

PMID: 37841186 PMC: 10568708. DOI: 10.1021/acsomega.3c04684.

References

Schellekens G, Visser H, de Jong B, van den Hoogen F, Hazes J, Breedveld F . The diagnostic properties of rheumatoid arthritis antibodies recognizing a cyclic citrullinated peptide. Arthritis Rheum. 2000; 43(1):155-63. DOI: 10.1002/1529-0131(200001)43:1<155::AID-ANR20>3.0.CO;2-3. View

Kallenberg C, Mulder A, Tervaert J . Antineutrophil cytoplasmic antibodies: a still-growing class of autoantibodies in inflammatory disorders. Am J Med. 1992; 93(6):675-82. DOI: 10.1016/0002-9343(92)90202-m. View

Steiner G, Hartmuth K, Skriner K, Sinski A, Thalmann E, Hassfeld W . Purification and partial sequencing of the nuclear autoantigen RA33 shows that it is indistinguishable from the A2 protein of the heterogeneous nuclear ribonucleoprotein complex. J Clin Invest. 1992; 90(3):1061-6. PMC: 329965. DOI: 10.1172/JCI115921. View

Goldbach-Mansky R, Lee J, McCoy A, Hoxworth J, Yarboro C, Smolen J . Rheumatoid arthritis associated autoantibodies in patients with synovitis of recent onset. Arthritis Res. 2000; 2(3):236-43. PMC: 17811. DOI: 10.1186/ar93. View

Schaller M, Burton D, Ditzel H . Autoantibodies to GPI in rheumatoid arthritis: linkage between an animal model and human disease. Nat Immunol. 2001; 2(8):746-53. DOI: 10.1038/90696. View

Forslind K, Vincent C, Serre G, Svensson B . Antifilaggrin autoantibodies in early rheumatoid arthritis. Scand J Rheumatol. 2000; 29(5):320-2. DOI: 10.1080/030097400447714. View

Blass S, Meier C, Vohr H, Schwochau M, Specker C, Burmester G . The p68 autoantigen characteristic of rheumatoid arthritis is reactive with carbohydrate epitope specific autoantibodies. Ann Rheum Dis. 1998; 57(4):220-5. PMC: 1752572. DOI: 10.1136/ard.57.4.220. View

Despres N, Boire G, Lopez-Longo F, Menard H . The Sa system: a novel antigen-antibody system specific for rheumatoid arthritis. J Rheumatol. 1994; 21(6):1027-33. View

Tarkowski A, Klareskog L, Carlsten H, Herberts P, Koopman W . Secretion of antibodies to types I and II collagen by synovial tissue cells in patients with rheumatoid arthritis. Arthritis Rheum. 1989; 32(9):1087-92. DOI: 10.1002/anr.1780320906. View

10.

Gabriel S . The epidemiology of rheumatoid arthritis. Rheum Dis Clin North Am. 2001; 27(2):269-81. DOI: 10.1016/s0889-857x(05)70201-5. View

11.

Ezaki I, Okada M, Yoshikawa Y, Fujikawa Y, Hashimoto M, Otsuka M . Human monoclonal rheumatoid factors augment arthritis in mice by the activation of T cells. Clin Exp Immunol. 1996; 104(3):474-82. PMC: 2200454. DOI: 10.1046/j.1365-2249.1996.55764.x. View

12.

Vencovsky J, Machacek S, Sedova L, Kafkova J, Gatterova J, Pesakova V . Autoantibodies can be prognostic markers of an erosive disease in early rheumatoid arthritis. Ann Rheum Dis. 2003; 62(5):427-30. PMC: 1754544. DOI: 10.1136/ard.62.5.427. View

13.

Aho K, Palosuo T, Heliovaara M, Knekt P, Alha P, von Essen R . Antifilaggrin antibodies within "normal" range predict rheumatoid arthritis in a linear fashion. J Rheumatol. 2000; 27(12):2743-6. View

14.

Palosuo T, Lukka M, Alenius H, Kalkkinen N, Aho K, Kurki P . Purification of filaggrin from human epidermis and measurement of antifilaggrin autoantibodies in sera from patients with rheumatoid arthritis by an enzyme-linked immunosorbent assay. Int Arch Allergy Immunol. 1998; 115(4):294-302. DOI: 10.1159/000069460. View

15.

Girbal-Neuhauser E, Durieux J, Arnaud M, Dalbon P, Sebbag M, Vincent C . The epitopes targeted by the rheumatoid arthritis-associated antifilaggrin autoantibodies are posttranslationally generated on various sites of (pro)filaggrin by deimination of arginine residues. J Immunol. 1999; 162(1):585-94. View

16.

Cordonnier C, Meyer O, Palazzo E, De Bandt M, Elias A, Nicaise P . Diagnostic value of anti-RA33 antibody, antikeratin antibody, antiperinuclear factor and antinuclear antibody in early rheumatoid arthritis: comparison with rheumatoid factor. Br J Rheumatol. 1996; 35(7):620-4. DOI: 10.1093/rheumatology/35.7.620. View

17.

Smolen J, Steiner G . Are autoantibodies active players or epiphenomena?. Curr Opin Rheumatol. 1998; 10(3):201-6. DOI: 10.1097/00002281-199805000-00008. View

18.

NIENHUIS R, MANDEMA E . A NEW SERUM FACTOR IN PATIENTS WITH RHEUMATOID ARTHRITIS; THE ANTIPERINUCLEAR FACTOR. Ann Rheum Dis. 1964; 23:302-5. PMC: 1030930. DOI: 10.1136/ard.23.4.302. View

19.

Pai S, Pai L, Birkenfeldt R . Correlation of serum IgA rheumatoid factor levels with disease severity in rheumatoid arthritis. Scand J Rheumatol. 1998; 27(4):252-6. DOI: 10.1080/030097498442352. View

20.

Wooley P, Luthra H, Singh S, Huse A, Stuart J, David C . Passive transfer of arthritis to mice by injection of human anti-type II collagen antibody. Mayo Clin Proc. 1984; 59(11):737-43. DOI: 10.1016/s0025-6196(12)65583-9. View